Loading clinical trials...
Loading clinical trials...
Phase III Study of Immune Globulin Intravenous (Human) IGIV-SN in Pediatric Subjects With Primary Humoral Immunodeficiency
Conditions
Interventions
Immunoglobulin
Start Date
April 30, 2019
Primary Completion Date
April 30, 2019
Completion Date
April 30, 2019
Last Updated
July 7, 2020
NCT03266627
NCT04197596
NCT02888535
NCT04354818
NCT01888484
NCT00538915
Lead Sponsor
Green Cross Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions